Other studies have confirmed that exosomal PD-L1, EVs containing PD-L1, and exosomal PD-L1 mRNA can be detected in melanoma, prostate cancer, breast cancer, glioblastoma, head and neck cancer, lung cancer, and other tumors (8–15) (Table 1). This evidence concerns the gene CD274 and lung carcinoma.